Quartier P, et al. - This study represents an attempt to gauge the efficacy and safety of adalimumab on uveitis in patients with early onset, chronic, juvenile idiopathic arthritis (JIA)-associated or idiopathic anterior uveitis and an inadequate response to topical steroids and methotrexate (MTX). Findings supported the use of adalimumab in patients with early onset, chronic anterior uveitis, which was found to be related to JIA in most cases, in case of inadequate response to topical therapy and MTX. Furthermore, for the assessment of early treatment efficacy, laser flare photometry could serve as a valuable tool.